PA
Therapeutic Areas
Regentis Biomaterials Pipeline
| Drug | Indication | Phase |
|---|---|---|
| GelrinC | Focal cartilage defects of the knee (osteochondral lesions) | Phase 2 |
| GelrinS / Platform Derivatives | Wound Healing (e.g., Diabetic Foot Ulcers) | Pre-clinical |
| Drug | Indication | Phase |
|---|---|---|
| GelrinC | Focal cartilage defects of the knee (osteochondral lesions) | Phase 2 |
| GelrinS / Platform Derivatives | Wound Healing (e.g., Diabetic Foot Ulcers) | Pre-clinical |